Global cardiovascular risk in a young adult at a polyclinic in Santiago de Cuba

Authors

Abstract

Introduction: Cardiovascular diseases represent the leading cause of death and disability worldwide. Global cardiovascular risk in young adults is a topic that has been scarcely studied in primary health care in Cuba. Atherosclerosis constitutes one of the underlying pathological processes, which progresses over the years; therefore, by the time symptoms manifest, the disease is usually already in an advanced stage.

Objective: To describe the global cardiovascular risk factors in young adults belonging to the Carlos J. Finlay polyclinic.

Methods: A descriptive, cross-sectional study was conducted at the "Carlos J. Finlay" polyclinic in the municipality of Santiago de Cuba, over a one-year period, in a population of young adults of both sexes aged between 25 and 44 years.

Results: The results showed a predominance of cardiovascular risk in young adults between 25 and 34 years of age (78.4%), a highly significant finding, with greater incidence in females (61.1%). The cardiac causal factors with the highest prevalence were tobacco smoking, alcoholism, and diabetes mellitus.

Conclusions: It was demonstrated that there is a high number of young adults with global cardiovascular risk, which predisposes them to developing this type of disease in the future.

Downloads

Download data is not yet available.

References

1.Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021[citado 24/02/2026];42(34):3227-337. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34458905/

2. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020[citado 12/01/2026];41(1):111-88. Disponible en: doi: 10.1093/eurheartj/ehz455

3.World Health Organization. BMI classification. Copenhagen: WHO Regional Office for Europe; 2022 [citado 12/01/2026]. Disponible en: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi

4. National Center for Health Statistics. National Health Interview Survey: tobacco use glossary. Atlanta: Centers for Disease Control and Prevention; 2022 [citado 10/02/2026]. Disponible en: https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm

5. SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021[citado 20/02/2026];42(25):2439-54.Disponible en: 10.1093/eurheartj/ehab309.

6. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2021. La Habana: MINSAP; 2022 [citado 16/12/2023]. Disponible en: https://instituciones.sld.cu/fatesa/files/2022/11/Anuario-Estad%C3%ADstico-de-Salud-2021.-Ed

7. SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021[citado 16/12/2023];42(25):2455-67. DOI: 10.1093/eurheartj/ehab312.

8. Ramos R, Masana L, Comas-Cufí M, García-Gil M, Martí-Lluch R, Ponjoan A, et al. Derivation and validation of SIDIAP-FHP score: a new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype. Atherosclerosis. 2020[citado 16/12/2023];292 :42-51. DOI: 10.1016/j.atherosclerosis.2019.10.016.

9. Pérez-Jiménez F, Pascual V, Meco JF, Pérez-Martínez P, Delgado-Lista J, Domenech M, et al. Documento de recomendaciones de la SEA 2019: el estilo de vida en la prevención cardiovascular. Clin Investig Arterioscler. 2019[citado 16/12/2023]; 31(6):280-310. DOI: 10.1016/j.arteri.2018.06.005.

10. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2021 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2021[citado 16/12/2023];52(10):e344-e418. DOI: 10.1161/STR.0000000000000375.

11.Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019[citado 16/12/2023];380(1):11-22. DOI: 10.1056/NEJMoa1812792.

12.Samuel M, Tardif JC, Bouabdallaoui N, Khairy P, Dubé MP, Blondeau L, et al. Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol. 2021[citado 16/12/2023];37(5):776-85. DOI:: 10.1016/j.cjca.2020.10.006.

13. Royo Bordonada MÁ, Armario P, Lobos-Bejarano JM, Pedro-Botet J, Villar-Alvarez F, Elosua R, et al. Adaptación española de las guías europeas sobre prevención de la enfermedad cardiovascular en la práctica clínica. Semergen. 2022[citado 16/12/2023];48(5):295-311. DOI: 10.1016/j.semerg.2021.11.012.

14. Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021[citado 16/12/2023];397(10285):1625-36. DOI:10.1016/S0140-6736(21)00590-0.

15. Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, Basora J, Fitó M, Corella D, et al. Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial. Diabetes Care. 2019[citado 16/12/2023];42(5):777-88. DOI:10.2337/dc18-0836.

16. Armario P, Jericó C, Vila L, Freixa R, Castillejos M, Rotllan M. Área de Atención Integrada de Riesgo Vascular: un nuevo modelo organizativo para el control global de los factores de riesgo. Hipertens Riesgo Vasc. 2017[citado 16/12/2023];34(2):72-7. DOI: 10.1016/j.hipert.2016.10.004.

17. Brotons C, Alemán JJ, Banegas JR, Fondón C, Lobos-Bejarano JM, Martín E, et al. Recomendaciones preventivas cardiovasculares: actualización PAPPS 2022. Aten Primaria. 2022[citado 16/12/2023];54(Supl 1):4-28.

18. Mostaza JM, Pintó X, Armario P, Masana L, Real JT, Valdivielso P, et al. SEA 2024 Standards for Global Control of Vascular Risk. Clin Investig Arterioscler. 2024[citado 16/12/2023];36(3):133-94. DOI: 10.1016/j.arteri.2024.02.001.

19. Carrero-Vázquez AM, Pérez-Rivera T, Martínez-García G, González-Migueles Y, Cisneros-Betancourt LG, Martínez-Peró RM. Mortalidad por enfermedades cardiovasculares en la Unidad de Cuidados Coronarios del Hospital "Enrique Cabrera": enero 2017-enero 2020. CorSalud. 2022[citado 16/12/2023];14(1):19-26. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/684

20. Zavala-Rubio JD, Rivera-Montellano ML, Sánchez-Martínez S, De la Mata-Márquez MJ, Torres-Rodríguez MM. Prevalencia de factores y estratificación de riesgo cardiovascular en personal que labora en una unidad de medicina familiar. Aten Fam [Internet]. 2019[citado 16/12/2023];25(4):129-33. Disponible en: https://www.medigraphic.com/pdfs/atefam/af-2019/af194c.pdf

Published

2026-04-17

How to Cite

1.
Olivares Alvarez DR, Veranes Mustelier Y, Tarazón Miclín O, Campos Muñoz M, Chiang Cutie EA. Global cardiovascular risk in a young adult at a polyclinic in Santiago de Cuba. MEDISAN.Revista médica Santiago [Internet]. 2026 Apr. 17 [cited 2026 Jul. 18];30:e5490. Available from: https://medisan.sld.cu/index.php/san/article/view/5490

Issue

Section

Original Articles